News & Press Releases

Mintz advised the underwriters in connection with a $661 million public offering by Praxis Precision Medicines of 2,543,800 shares of common stock (which includes 331,800 shares of common stock issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares of common stock) at a public offering price of $260.00 per share.

Mintz advised User Interviews, the leading participant recruitment platform for user and market research and AI training, on its sale to UserTesting, the leading provider of customer insights for enterprise-scale companies. UserTesting was acquired by funds affiliated with Thoma Bravo and Sunstone Partners in 2022.

Siegmund Gutman, Life Science Litigation Practice Chair and Patent Litigation Practice Co-Chair, was quoted by Bloomberg Law in an article focused on the biggest patent lawsuits surrounding pharmaceutical drugs and technologies that are set to go to trial in 2026.

Mintz advised Charlesbank Capital Partners (Charlesbank), a middle-market private equity firm, on its strategic growth investment in HBox, a leading virtual care platform for specialty practices. 

Mintz is pleased to have represented Royal Philips, a global leader in health technology, in entering into an agreement to acquire SpectraWAVE, Inc., an innovator in Enhanced Vascular Imaging of coronary arteries, angiography-based physiology assessments, and the use of AI in medical imaging. SpectraWAVE’s intravascular imaging and physiological assessment technologies provide advanced solutions for the treatment of patients with coronary artery disease, affecting more than 300 million people worldwide. 

Mintz advised TPG on Cencora’s acquisition of TPG’s equity interest in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology. The transaction follows a period of significant physician-led investment and growth for the platform.